Immunogenic composition
OwnerAndre Gorenflot, Eric Precigout +2inventors
InventorsAndre Gorenflot, Eric Precigout, Stephane Delbecq, Theodorus Schetters
Life of this patent
Estimating the term…
Loading patent…
OwnerAndre Gorenflot, Eric Precigout +2inventors
InventorsAndre Gorenflot, Eric Precigout, Stephane Delbecq, Theodorus Schetters
Estimating the term…
The present invention provides an immunogenic composition comprising a fusion protein and a saponin adjuvant. The fusion protein comprises a heterologous hydrophobic peptide that is fused to the N-terminus and/or to the C-terminus of a core polypeptide. The core polypeptide comprises at least one protective epitope. The saponin adjuvant in this composition is present in a free form. Also provided are vaccines comprising the immunogenic composition and optionally an additional immunoactive component. Methods for the preparation of such vaccines, and use of the immunogenic composition for the manufacture of a vaccine are provided as well.
An immunogenic composition comprising a fusion protein and a saponin adjuvant, characterized in that the fusion protein comprises a heterologous hydrophobic peptide which is fused to the N-terminus and/or to the C-terminus of a core polypeptide, the core polypeptide comprising at least one protective epitope, the saponin adjuvant being in a free form.
(canceled)
Dependencies are inferred from the claim text.